Delcath Systems, Inc.
Delcath Systems, Inc. is a US-based company specialising in innovative medical technologies within the precision and optical instruments sector, including watches and clocks. Headquartered in the United States, the company operates across multiple regions, focusing on developing advanced treatments for cancer patients. Founded in 1988, Delcath has established a strong reputation for its proprietary drug delivery systems, notably its Hepatic Delivery System, which offers targeted therapy for liver cancers.
The company's core offerings centre on its unique approach to delivering high-dose chemotherapy directly to tumours while minimising systemic exposure. This innovative method has positioned Delcath as a leader in the field of interventional oncology. With notable milestones in clinical development and regulatory approvals, Delcath continues to advance its market position as a pioneer in precision medical solutions.
-16 vs industry average
Delcath Systems, Inc.’s score of 13 is lower than 26% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Delcath Systems, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has below-average carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for Delcath Systems, Inc. yet.
Delcath Systems, Inc.'s reported carbon emissions
Delcath Systems, Inc., headquartered in the US and operating within the Medical, precision and optical instruments, watches and clocks industry (33), has not publicly disclosed specific carbon emissions data for recent years. Therefore, information regarding their absolute emissions in kg CO2e, including Scope 1, Scope 2, and Scope 3, is not available.
Consequently, details on their reduction targets, such as Science Based Targets initiative (SBTi) commitments or participation in initiatives like the Climate Pledge, are also not publicly documented at this time. As a company in the medical instruments sector, Delcath Systems may be subject to evolving environmental regulations and industry best practices concerning greenhouse gas emissions and climate impact. Further disclosures on their climate strategy and performance are anticipated.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Delcath Systems, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Delcath Systems, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Delcath Systems, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project